1. Lyter DW, Bryant J, Tackeray R, et al. Incidence of human immunodeficiency virus related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 13 (10): 2540–2546, 1995.
2. Centers for Disease Control: First 500,000 cases-United States, 1995. Morbid Mortal Weekly Rep 44:849–853, 1995.
3. Jacobson LP, et al. Impact of highly effective anti-retroviral therapy on the incidence of malignancies among HIV-infected individuals. The Second Natl AIDS Malignancy Conference (abstract) S5, 1998.
4. Wiggins CL, Aboulafia DM, Ryland LM, et al. Decline in HIV-associated Kaposi’s sarcoma (KS) and non-Hodgkin’s lymphoma (NHL) following the introduction of highly active antiretroviral therapy (HAART). The Third Natl AIDS Malignancy Conference (abstract) 21(1): A15, 1999.
5. Nichols CM, Fraitz CM, Hicks MJ. Treating Kaposi’s lesions in the HIV-infected patient. J Am Dent Assoc 124:78, 1993.